Free Trial

Enanta Pharmaceuticals (ENTA) SEC Filings & 10K Form

Enanta Pharmaceuticals logo
$6.30 +0.02 (+0.32%)
(As of 02:02 PM ET)

Recent Enanta Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/10/2024
4:03 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:08 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:12 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:29 AM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
5:28 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:32 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:35 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:37 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:41 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:01 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:03 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:04 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:06 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:08 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:10 PM
Enanta Pharmaceuticals (Issuer)
Kowalsky Matthew Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
7:35 AM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/25/2024
3:05 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:03 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
10/17/2024
3:31 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
08/09/2024
4:24 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:00 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
4:29 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:30 PM
Enanta Pharmaceuticals (Subject)
Rottinghaus Scott T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
7:38 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:23 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:15 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:19 PM
Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:12 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:31 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:11 PM
Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
Form SCHEDULE 13G
02/14/2024
7:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:23 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:00 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:09 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:12 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:15 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:18 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
11:15 PM
Enanta Pharmaceuticals (Filer)
Form EFFECT
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

01/26/2024
8:11 AM
Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
01/24/2024
4:23 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
11:25 AM
Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/11/2024
3:15 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ENTA) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners